Healthpeak Properties
Stock Forecast, Prediction & Price Target
Healthpeak Properties (DOC) stock Price Target by analysts
$28
Potential upside: 62.61%
Healthpeak Properties price prediction
What is Healthpeak Properties stock analysts` prediction?
Healthpeak Properties stock forecast: Based on 1 Wall Street analysts` predicted price targets for Healthpeak Properties in the last 3 months, the avarage price target is $28, with a high forecast of $NaN. The average price target represents a 62.61% change from the last price of $17.22.
Disclaimer: This is not investment advice. Don't use price targets as the only investment indicator. Always remember to do your own thorough research and due diligence before making an investment decision.
Healthpeak Properties stock Price Target by analysts
Full breakdown of analysts given Healthpeak Properties price targets
| Analyst name & company | Analyst win rate | Publish date | Price target | Price when posted | Source | Historical targets |
|---|---|---|---|---|---|---|
Omotayo Okusanya Deutsche Bank | 0% 0/1 | 11 months ago | $28 62.61% upside | $22.64 | TheFly | Previous targets (0) |
Nick Joseph Citigroup | 0% 0/1 | about 1 year ago | $22 27.76% upside | $21.89 | TheFly | Previous targets (0) |
Michael Carroll RBC Capital | 0% 0/2 | about 1 year ago | $25 45.18% upside | $21.85 | StreetInsider | Previous targets (1) |
Wesley Golladay Robert W. Baird | 0% 0/1 | about 1 year ago | $24 39.38% upside | $21.85 | StreetInsider | Previous targets (0) |
Richard Anderson Wedbush | 0% 0/1 | over 1 year ago | $22 27.76% upside | $19.17 | StreetInsider | Previous targets (0) |
Michael Carroll RBC Capital | 0% 0/2 | over 1 year ago | $22 27.76% upside | $19.34 | StreetInsider | Previous targets (1) |
Unknown Robert W. Baird | N/A | over 1 year ago | $22 27.76% upside | $18.31 | StreetInsider | N/A |
Connor Siversky Wells Fargo | 100% 1/1 | over 1 year ago | $19 10.34% upside | $17.54 | StreetInsider | Previous targets (0) |
Omotayo Okusanya Credit Suisse | 100% 1/1 | about 2 years ago | $15 -12.88% downside | $14.64 | Benzinga | Previous targets (0) |
Unknown Morgan Stanley | N/A | about 3 years ago | $16.5 -4.17% downside | $16.95 | Benzinga | N/A |
Unknown Morgan Stanley | N/A | about 3 years ago | $16 -7.07% downside | $16.76 | Benzinga | N/A |
Unknown Truist Financial | N/A | about 3 years ago | $17 -1.27% downside | $16.58 | Benzinga | N/A |
Unknown Jefferies | N/A | about 3 years ago | $20 16.15% upside | $17.58 | Benzinga | N/A |
Unknown Morgan Stanley | N/A | over 3 years ago | $17.5 1.63% upside | $18.55 | Benzinga | N/A |
Unknown Barclays | N/A | over 3 years ago | $20 16.15% upside | $17.58 | Benzinga | N/A |
Michael R Lewis Truist Financial | 100% 1/1 | over 4 years ago | $19 10.34% upside | $17.26 | StreetInsider | Previous targets (0) |
Healthpeak Properties Financial Estimates
Healthpeak Properties Revenue Estimates
Healthpeak Properties EBITDA Estimates
Healthpeak Properties Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | |
Revenue
% change YoY
| $457.69M N/A | $526.63M 15.06% | $2.18B 314.13% | Avg: $580.68M Low: $527.89M High: $618.69M avg. -73.37% | Avg: $561.82M Low: $511.57M High: $591.69M avg. -3.24% | Avg: $3.28B Low: $2.99B High: $3.46B avg. 485.23% | |
Net Income
% change YoY
| $25.39M N/A | $37.80M 48.83% | $306.00M 709.50% | Avg: $60.26M Low: $114.92M High: $139.39M avg. -80.30% | Avg: $76.19M Low: $96.73M High: $117.01M avg. 26.42% | Avg: $0 Low: $0 High: $0 avg. -100% | |
EBITDA
% change YoY
| $280.96M N/A | $314.53M 11.94% | $1.18B 278.14% | Avg: $348.82M Low: $317.11M High: $371.66M avg. -70.67% | Avg: $337.50M Low: $307.31M High: $355.44M avg. -3.24% | Avg: $1.97B Low: $1.79B High: $2.08B avg. 485.23% | |
EPS
% change YoY
| $0.05 N/A | $0.07 49.04% | $0.56 697.72% | Avg: $0.22 Low: $0.21 High: $0.25 avg. -59.83% | Avg: $0.2 Low: $0.18 High: $0.21 avg. -11.07% | Avg: $0 Low: $0 High: $0 avg. -100% | |
Operating Expenses
% change YoY
| $195.62M N/A | $229.85M 17.49% | $103.13M -55.13% | Avg: $41.73M Low: $37.93M High: $44.46M avg. -59.53% | Avg: $40.37M Low: $36.76M High: $42.52M avg. -3.24% | Avg: $236.29M Low: $215.16M High: $248.86M avg. 485.23% | |
FAQ
What is Healthpeak Properties stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of -17.96% in 2025-2027.
We have gathered data from 5 analysts. Their low estimate is 114.92M, average is 60.26M and high is 139.39M.
What is Healthpeak Properties stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 136.20% in 2025-2027.
We have gathered data from 6 analysts. Their low revenue estimate is $527.89M, average is $580.68M and high is $618.69M.
What is Healthpeak Properties stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of -23.63% in 2025-2027.
We have gathered data from 5 analysts. Their low earnings per share estimate is $0.21, average is $0.22 and high is $0.25.
What is the best performing analyst?
In the last twelve months 1 analysts have been covering Healthpeak Properties stock. The most successful analyst is Omotayo Okusanya.